|Bid||2.2700 x 1000|
|Ask||2.3000 x 1200|
|Day's Range||2.0300 - 2.3129|
|52 Week Range||1.3300 - 4.1300|
|Beta (5Y Monthly)||1.49|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.75|
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that an IND (Investigational New Drug) application for its prophylactic breast cancer vaccine has been filed with the U.S. Food and Drug Administration.
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced it will hold a conference call on November 2, 2020 at 1:30 p.m. Pacific / 4:30 p.m. Eastern.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...